Hussman Strategic Advisors, Inc. Standard Biotools Inc. Transaction History

Hussman Strategic Advisors, Inc.

  • $386 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021
SELL
$5.5 - $7.41 $792,000 - $1.07 Million
-144,000 Closed
0 $0
Q1 2021

May 03, 2021
SELL
$3.94 - $7.09 $236,400 - $425,400
-60,000 Reduced 29.41%
144,000 $651,000
Q3 2020

Nov 02, 2020
BUY
$4.34 - $11.43 $885,360 - $2.33 Million
204,000 New
204,000 $1.52 Million

Others Institutions Holding LAB

# of Institutions
143
Shares Held
276M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $127M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email